Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient

Transplantation Proceedings

Volumn 35, Issue 2, 2003, Pages 627-628

  Shitrit, D ^a   Starobin, D ^a   Aravot, D ^b   Fink, G ^a   Izbicki, G ^c   Kramer, M ^a,b  

^a Pulmonary Institute   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME;

EID: 0037342314     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00015-0     Document Type: Conference Paper

References (11)

1. Trimarchi HM, Truong LD, Brennan S, et al: Transplantation 67:539, 1999.
2. Myers J.N., Shabshab S.F., Burton N.A., et al. J Heart Lung Transplant. 18:1999;1024.
3. Klintman G. Transplantation Rev. 8:1994;53.
4. Transplant Proc. 25:1993;624.
5. Katari S., Magnone M., Shapiro R., et al. Clin Transplant. 11:1997;237.
6. Singh N., Gayowski T., Marino I.R. Transplant Int. 9:1998;68.
7. Randhawa P.S., Shapiro R., Jordan M.L., et al. Am J Surg Pathol. 17:1993;60.
8. Randhawa P.S., Tsamandas A.C., Magnone M., et al. Am J Surg Pathol. 20:1996;306.
9. Mihatsch M.J., Kyo M., Morozumi T., et al. Clin Nephrol. 49:1998;356.
10. Daufman D.B., Kaplan B., Kanwar Y.S., et al. Transplantation. 59:1995;1737.
11. Abdalla A.H., Al-Sulaiman M.H., Al-Khader A.A. Transplant Int. 7:1994;382.